Literature DB >> 19327519

Surgical management of multiple ventricular septal defects: the role of the felt sandwich technique.

Naoki Yoshimura1, Hironori Matsuhisa, Shingo Otaka, Junichiro Kitahara, Hirohisa Murakami, Keiichiro Uese, Fukiko Ichida, Takuro Misaki.   

Abstract

OBJECTIVE: Recently, the felt sandwich technique has been widely used to close muscular ventricular septal defects. We evaluated the early and midterm results of our strategy (a combination of the sandwich technique and direct closures) and assessed the role of the sandwich technique in the treatment of multiple ventricular septal defects.
METHODS: Twenty-nine consecutive patients underwent an operation for multiple ventricular septal defects and associated cardiac malformations. They included 17 boys and 12 girls with a median age of 6.0 months. Thirteen patients had 4 or more ventricular septal defects (Swiss cheese septum).
RESULTS: There was no surgical or follow-up mortality, and no reoperations were required. There were no cases of heart block and no significant residual shunts in the latest follow-up study. Two patients with Swiss cheese septum had postoperative congestive heart failure. Three muscular ventricular septal defects were closed with the sandwich technique in these 2 patients, whereas 1 or fewer ventricular septal defects were closed with the sandwich technique in the other 27 patients. Seven (77.8%) of 9 patients who underwent the sandwich procedure had septal dysfunction, whereas 5 (25.0%) of the other 20 patients showed septal dysfunction (P < .05).
CONCLUSIONS: The outcome of the surgical repair of multiple ventricular septal defects was satisfactory. Although the sandwich technique is simple and effective, the use of numerous felt patches disturbed the movement of the interventricular septum. An effort should be made to close the muscular ventricular septal defect directly to avoid postoperative cardiac dysfunction. Large apical ventricular septal defects, especially those located just underneath the moderator band, are considered suitable for the sandwich technique.

Entities:  

Mesh:

Year:  2008        PMID: 19327519     DOI: 10.1016/j.jtcvs.2008.08.055

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Current topics in surgery for multiple ventricular septal defects.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Mari Sakai
Journal:  Surg Today       Date:  2015-05-03       Impact factor: 2.549

Review 2.  Techniques and results in the management of multiple muscular trabecular ventricular septal defects.

Authors:  Tetsuya Kitagawa; Takashi Kitaichi; Mikio Sugano; Hirotsugu Kurobe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-06-05

3.  Morphogenetic aspects of the septomarginal trabecula in the human heart.

Authors:  Adam Kosiński; Dariusz Kozłowski; Janusz Nowiński; Ewa Lewicka; Alicja Dąbrowska-Kugacka; Grzegorz Raczak; Marek Grzybiak
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

4.  Epicardial deployment of right ventricular disk during perventricular device closure in a child with apical muscular ventricular septal defect.

Authors:  Nageswara Rao Koneti; Sudeep Verma; Shweta Bakhru; Karunakar Vadlamudi; Pallavi Kathare; Br Jagannath
Journal:  Ann Pediatr Cardiol       Date:  2013-07

5.  Multiple ventricular septal defects: a new strategy.

Authors:  Antonio F Corno; Pramod R Kandakure; Ramana Rao V Dhannapuneni; Gordon Gladman; Prem Venugopal; Nelson Alphonso
Journal:  Front Pediatr       Date:  2013-07-31       Impact factor: 3.418

6.  Biventricular surgical repair of "Swiss Cheese" ventricular septal defects with two-patch and right ventricle apex excluding technique: preliminary experience and clinical results.

Authors:  Qin Wu; Lei Shi; Rui Chen; Quansheng Xing
Journal:  J Cardiothorac Surg       Date:  2021-03-20       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.